Franklin Covey (FC)
(Delayed Data from NYSE)
$39.54 USD
+0.21 (0.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $39.49 -0.05 (-0.13%) 5:34 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Income Statements
Fiscal Year end for Franklin Covey Company falls in the month of August .
All items in Millions except EPS data.
8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 | |
---|---|---|---|---|---|
Sales | 281 | 263 | 224 | 198 | 225 |
Cost Of Goods | 67 | 61 | 51 | 53 | 66 |
Gross Profit | 213 | 202 | 173 | 145 | 159 |
Selling & Adminstrative & Depr. & Amort Expenses | 187 | 178 | 165 | 142 | 157 |
Income After Depreciation & Amortization | 26 | 24 | 8 | 3 | 3 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 2 | 2 | 2 | 2 | 2 |
Pretax Income | 26 | 22 | 6 | 1 | 1 |
Income Taxes | 8 | 4 | -8 | 10 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 18 | 18 | 14 | -9 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 18 | 18 | 14 | -9 | -1 |
Depreciation Footnote | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 39 | 38 | 24 | 19 | 19 |
Depreciation & Amortization (Cash Flow) | 13 | 14 | 16 | 16 | 16 |
Income After Depreciation & Amortization | 26 | 24 | 8 | 3 | 3 |
Earnings Per Share Data | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Average Shares | 14.30 | 14.56 | 14.14 | 13.89 | 13.95 |
Diluted EPS Before Non-Recurring Items | 1.24 | 1.02 | 0.96 | 0.14 | -0.07 |
Diluted Net EPS (GAAP) | 1.24 | 1.27 | 0.96 | -0.68 | -0.07 |
Fiscal Year end for Franklin Covey Company falls in the month of August .
All items in Millions except EPS data.
2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 | |
---|---|---|---|---|---|
Sales | 61.34 | 68.40 | 77.95 | 71.44 | 61.76 |
Cost Of Goods | 14.49 | 16.12 | 18.65 | 17.21 | 14.55 |
Gross Profit | 46.85 | 52.28 | 59.30 | 54.23 | 47.21 |
SG&A, R&D, and Dept/Amort Expenses | 45.41 | 46.95 | 48.74 | 47.66 | 44.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1.44 | 5.33 | 10.56 | 6.57 | 2.83 |
Non-Operating Income | 0.30 | 0.29 | 0.29 | 0.36 | 0.36 |
Interest Expense | 0.33 | 0.34 | 0.41 | 0.35 | 0.41 |
Pretax Income | 1.42 | 5.28 | 10.45 | 6.58 | 2.78 |
Income Taxes | 0.54 | 0.43 | 3.63 | 2.02 | 1.04 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.87 | 4.85 | 6.81 | 4.56 | 1.74 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.87 | 4.85 | 6.81 | 4.56 | 1.74 |
Earnings Per Share Data | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 |
---|---|---|---|---|---|
Average Shares | 13.48 | 13.64 | 13.89 | 14.27 | 14.53 |
Diluted EPS Before Non-Recurring Items | 0.06 | 0.36 | 0.49 | 0.32 | 0.12 |
Diluted Net EPS (GAAP) | 0.06 | 0.36 | 0.48 | 0.32 | 0.12 |